162 related articles for article (PubMed ID: 11083027)
1. Heme metabolism after discontinued hexachlorobenzene administration in rats: possible irreversible changes and biomarker for hexachlorobenzene persistence.
De Catabbi SCB ; Aldonatti C; de Viale LC
Comp Biochem Physiol C Toxicol Pharmacol; 2000 Sep; 127(2):165-75. PubMed ID: 11083027
[TBL] [Abstract][Full Text] [Related]
2. Heme metabolism and lipid peroxidation in rat kidney hexachlorobenzene-induced porphyria: A compartmentalized study of biochemical pathogenic mechanisms.
Fernández-Tomé MC; Billi de Catabbi SC; Aldonatti C; San Martin de Viale LC; Sterin-Speziale NB
Kidney Blood Press Res; 2000; 23(1):20-6. PubMed ID: 10567850
[TBL] [Abstract][Full Text] [Related]
3. Studies on the mechanism of uroporphyrinogen decarboxylase inhibition in hexachlorobenzene-induced porphyria in the female rat.
Mylchreest E; Charbonneau M
Toxicol Appl Pharmacol; 1997 Jul; 145(1):23-33. PubMed ID: 9221820
[TBL] [Abstract][Full Text] [Related]
4. The role of oxidative metabolism in hexachlorobenzene-induced porphyria and thyroid hormone homeostasis: a comparison with pentachlorobenzene in a 13-week feeding study.
den Besten C; Bennik MH; Bruggeman I; Schielen P; Kuper F; Brouwer A; Koeman JH; Vos JG; Van Bladeren PJ
Toxicol Appl Pharmacol; 1993 Apr; 119(2):181-94. PubMed ID: 8480328
[TBL] [Abstract][Full Text] [Related]
5. Hexachlorobenzene impairs glucose metabolism in a rat model of porphyria cutanea tarda: a mechanistic approach.
Mazzetti MB; Taira MC; Lelli SM; Dascal E; Basabe JC; de Viale LC
Arch Toxicol; 2004 Jan; 78(1):25-33. PubMed ID: 12898129
[TBL] [Abstract][Full Text] [Related]
6. Time course of hexachlorobenzene-induced alterations of lipid metabolism and their relation to porphyria.
Billi de Catabbi S; Sterin-Speziale N; Fernandez MC; Minutolo C; Aldonatti C; San Martín de Viale L
Int J Biochem Cell Biol; 1997 Feb; 29(2):335-44. PubMed ID: 9147135
[TBL] [Abstract][Full Text] [Related]
7. Thyroid function and thyroxine metabolism in hexachlorobenzene-induced porphyria.
Kleiman de Pisarev DL; Rios de Molina MC; San Martin de Viale LC
Biochem Pharmacol; 1990 Mar; 39(5):817-25. PubMed ID: 2310407
[TBL] [Abstract][Full Text] [Related]
8. Hexachlorobenzene-induced alterations on neutral and acidic sphingomyelinases and serine palmitoyltransferase activities. A time course study in two strains of rats.
Billi de Catabbi SC; Setton-Advruj CP; Sterin-Speziale N; San Martín de Viale LC; Cochón AC
Toxicology; 2000 Aug; 149(2-3):89-100. PubMed ID: 10967406
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of liver heme oxygenase in hexachlorobenzene-induced hepatic porphyria.
Stonard MD; Poli G; De Matteis F
Arch Toxicol; 1998 May; 72(6):355-61. PubMed ID: 9657283
[TBL] [Abstract][Full Text] [Related]
10. Dose-response relationships in hexachlorobenzene-induced porphyria.
Kennedy SW; Wigfield DC
Biochem Pharmacol; 1990 Sep; 40(6):1381-8. PubMed ID: 2403392
[TBL] [Abstract][Full Text] [Related]
11. The role of the Ah locus in hexachlorobenzene-induced porphyria. Studies in congenic C57BL/6J mice.
Hahn ME; Gasiewicz TA; Linko P; Goldstein JA
Biochem J; 1988 Aug; 254(1):245-54. PubMed ID: 2845946
[TBL] [Abstract][Full Text] [Related]
12. Glycogen metabolism and glucose transport in experimental porphyria.
Taira MC; Mazzetti MB; Lelli SM; de Viale LC
Toxicology; 2004 Apr; 197(2):165-75. PubMed ID: 15003326
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of uroporphyrin does not provoke further inhibition of liver uroporphyrinogen decarboxylase activity in hexachlorobenzene-induced porphyria.
Adjarov DG; Elder GH
IARC Sci Publ; 1986; (77):467-9. PubMed ID: 3596742
[TBL] [Abstract][Full Text] [Related]
14. Hepatocarcinogenicity of hexachlorobenzene in rats and the sex difference in hepatic iron status and development of porphyria.
Smith AG; Francis JE; Dinsdale D; Manson MM; Cabral JR
Carcinogenesis; 1985 Apr; 6(4):631-6. PubMed ID: 3986965
[TBL] [Abstract][Full Text] [Related]
15. Immune effects of hexachlorobenzene in the rat: role of metabolism in a 13-week feeding study.
Schielen P; Den Besten C; Vos JG; Van Bladeren PJ; Seinen W; Bloksma N
Toxicol Appl Pharmacol; 1995 Mar; 131(1):37-43. PubMed ID: 7878676
[TBL] [Abstract][Full Text] [Related]
16. The involvement of iron and lipid peroxidation in the pathogenesis of HCB induced porphyria.
Alleman MA; Koster JF; Wilson JH; Edixhoven-Bosdijk A; Slee RG; Kroos MJ; von Eijk HG
Biochem Pharmacol; 1985 Jan; 34(2):161-6. PubMed ID: 3966921
[TBL] [Abstract][Full Text] [Related]
17. Effects of sulfur-containing metabolites of hexachlorobenzene on the heme metabolic enzymes in rat liver.
Kato Y; Konishi S; Yamada S; Kimura R
J Pharmacobiodyn; 1990 May; 13(5):278-84. PubMed ID: 2273443
[TBL] [Abstract][Full Text] [Related]
18. [Behaviour of the hepatic glutathione (GSH) in the rat in continuous administration of hexachlorobenzene (HCB) (author's transl)].
Goerz G; Vizethum W; Lissner R
Derm Beruf Umwelt; 1979; 27(6):173-5. PubMed ID: 550992
[TBL] [Abstract][Full Text] [Related]
19. Development of an experimental model for the study of hexachlorobenzene-induced hepatic porphyria in the rat.
Krishnan K; Brodeur J; Charbonneau M
Fundam Appl Toxicol; 1991 Oct; 17(3):433-41. PubMed ID: 1794647
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic studies of the inhibition of hepatic uroporphyrinogen decarboxylase in C57BL/10 mice by iron-hexachlorobenzene synergism.
Smith AG; Francis JE; Kay SJ; Greig JB; Stewart FP
Biochem J; 1986 Sep; 238(3):871-8. PubMed ID: 3800966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
